Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake
Investors seem boyed by Ariad Pharmaceuticals’ decision Friday to adopt a plan designed to prevent takeovers, raising the company’s stock price 22 percent since the Friday morning announcement...
Related Articles
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Analyst: Icahn May Urge Separation of CEO. Chairman Roles at Nuance also written by Don Seiffert
- Why State Street is Giving Shareholders a Bigger Say over Its Board also published in Business News
- CEOs and Executives of Companies Filing for Bankruptcy Make Millions also categorized in BoardNews
- Elon Musk’s Staggering 2020 Earnings Revealed—And It’s More Than All Other CEOs also categorized in BoardNews
- Lululemon Strips Its Billionaire Founder Chip Wilson Of Board Appointment also categorized in BoardNews
- Care.com Shutting Down e-Commerce Firm it Previously Acquired, Loses Board Member also published in Business News
- Ford Fires CEO Mark Fields; Former Steelcase Chief Jim Hackett To Take Over also categorized in BoardNews
- Breaking News: Standley Is Out As Rite Aid CEO In Shakeup also categorized in BoardNews
- Agios Scores Biogen CFO as Board Member also written by Don Seiffert
Login to comment.